HEADER HYDROLASE 14-DEC-03 1V78 OBSLTE 07-NOV-06 1V78 2E1W TITLE CRYSTAL STRUCTURES OF ADENOSINE DEAMINASE COMPLEXED WITH TITLE 2 POTENT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENOSINE DEAMINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ADENOSINE AMINOHYDROLASE; COMPND 5 EC: 3.5.4.4 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE KEYWDS BETA BARREL, ZINC EXPDTA X-RAY DIFFRACTION AUTHOR T.KINOSHITA REVDAT 2 07-NOV-06 1V78 1 OBSLTE REVDAT 1 21-DEC-04 1V78 0 JRNL AUTH T.TERASAKA,H.OKUMURA,K.TSUJI,T.KATO,I.NAKANISHI, JRNL AUTH 2 T.KINOSHITA,Y.KATO,M.KUNO,N.SEKI,Y.NAOE,T.INOUE, JRNL AUTH 3 K.TANAKA,K.NAKAMURA JRNL TITL STRUCTURE-BASED DESIGN AND SYNTHESIS OF JRNL TITL 2 NON-NUCLEOSIDE, POTENT, AND ORALLY BIOAVAILABLE JRNL TITL 3 ADENOSINE DEAMINASE INHIBITORS JRNL REF J.MED.CHEM. V. 47 2728 2004 JRNL REFN ASTM JMCMAR US ISSN 0022-2623 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11679 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 595 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 12274 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2789 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1V78 COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.100 (2007-05-01) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-DEC-2003. REMARK 100 THE RCSB ID CODE IS RCSB006293. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-2003 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL24XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8266 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTAL CLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTAL CLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11679 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULPHATE, PEG400, MES REMARK 280 BUFFER, PH 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,1/2+Z REMARK 290 3555 1/2-Y,1/2+X,3/4+Z REMARK 290 4555 1/2+Y,1/2-X,1/4+Z REMARK 290 5555 1/2-X,1/2+Y,3/4-Z REMARK 290 6555 1/2+X,1/2-Y,1/4-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,1/2-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.73000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 39.20500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 39.20500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 103.09500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 39.20500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 39.20500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.36500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 39.20500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 39.20500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 103.09500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 39.20500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 39.20500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 34.36500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 68.73000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 GLN A 3 REMARK 465 MET A 353 REMARK 465 PRO A 354 REMARK 465 SER A 355 REMARK 465 PRO A 356 REMARK 465 ALA A 357 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 169 CA - CB - SG ANGL. DEV. =-21.7 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 131 -41.67 82.14 REMARK 500 GLU A 174 -70.65 52.66 REMARK 500 HIS A 238 -80.30 65.00 REMARK 500 ASP A 295 -66.23 74.18 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 36 ALA A 37 -120.99 REMARK 500 ALA A 37 LEU A 38 -139.49 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1V79 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH FR239087 REMARK 900 RELATED ID: 1V7A RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH FR247581 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE IN THIS ENTRY IS COINCIDENT WITH REMARK 999 THE SEQUENCE FROM THE FOLLOWING REFERENCE OF REMARK 999 SWISS-PROT. REMARK 999 J.PHARM.BIOMED.ANAL. VOL14, 1513-1519(1996) REMARK 999 PRIMARY STRUCTURE OF BOVINE ADENOSINE DEAMINASE. REMARK 999 KELLY M.A., VESTLING M.M., MURPHY C.M., HUA S., REMARK 999 SUMPTER T., FENSELAU C. DBREF 1V78 A 2 357 UNP P56658 ADA_BOVIN 1 356 SEQADV 1V78 ASP A 8 UNP P56658 ASN 7 SEE REMARK 999 SEQADV 1V78 LYS A 32 UNP P56658 ARG 31 SEE REMARK 999 SEQADV 1V78 ARG A 33 UNP P56658 LYS 32 SEE REMARK 999 SEQADV 1V78 THR A 57 UNP P56658 SER 56 SEE REMARK 999 SEQADV 1V78 ASP A 60 UNP P56658 GLU 59 SEE REMARK 999 SEQADV 1V78 ASP A 77 UNP P56658 GLU 76 SEE REMARK 999 SEQADV 1V78 ILE A 79 UNP P56658 VAL 78 SEE REMARK 999 SEQADV 1V78 GLN A 199 UNP P56658 LYS 198 SEE REMARK 999 SEQADV 1V78 THR A 246 UNP P56658 ALA 245 SEE REMARK 999 SEQADV 1V78 ILE A 261 UNP P56658 VAL 260 SEE REMARK 999 SEQADV 1V78 ALA A 279 UNP P56658 PRO 278 SEE REMARK 999 SEQADV 1V78 ILE A 281 UNP P56658 VAL 280 SEE REMARK 999 SEQADV 1V78 LYS A 313 UNP P56658 ASN 312 SEE REMARK 999 SEQADV 1V78 ASP A 314 UNP P56658 GLU 313 SEE REMARK 999 SEQADV 1V78 ARG A 352 UNP P56658 GLY 351 SEE REMARK 999 SEQRES 1 A 356 ALA GLN THR PRO ALA PHE ASP LYS PRO LYS VAL GLU LEU SEQRES 2 A 356 HIS VAL HIS LEU ASP GLY ALA ILE LYS PRO GLU THR ILE SEQRES 3 A 356 LEU TYR TYR GLY LYS ARG ARG GLY ILE ALA LEU PRO ALA SEQRES 4 A 356 ASP THR PRO GLU GLU LEU GLN ASN ILE ILE GLY MET ASP SEQRES 5 A 356 LYS PRO LEU THR LEU PRO ASP PHE LEU ALA LYS PHE ASP SEQRES 6 A 356 TYR TYR MET PRO ALA ILE ALA GLY CYS ARG ASP ALA ILE SEQRES 7 A 356 LYS ARG ILE ALA TYR GLU PHE VAL GLU MET LYS ALA LYS SEQRES 8 A 356 ASP GLY VAL VAL TYR VAL GLU VAL ARG TYR SER PRO HIS SEQRES 9 A 356 LEU LEU ALA ASN SER LYS VAL GLU PRO ILE PRO TRP ASN SEQRES 10 A 356 GLN ALA GLU GLY ASP LEU THR PRO ASP GLU VAL VAL SER SEQRES 11 A 356 LEU VAL ASN GLN GLY LEU GLN GLU GLY GLU ARG ASP PHE SEQRES 12 A 356 GLY VAL LYS VAL ARG SER ILE LEU CYS CYS MET ARG HIS SEQRES 13 A 356 GLN PRO SER TRP SER SER GLU VAL VAL GLU LEU CYS LYS SEQRES 14 A 356 LYS TYR ARG GLU GLN THR VAL VAL ALA ILE ASP LEU ALA SEQRES 15 A 356 GLY ASP GLU THR ILE GLU GLY SER SER LEU PHE PRO GLY SEQRES 16 A 356 HIS VAL GLN ALA TYR ALA GLU ALA VAL LYS SER GLY VAL SEQRES 17 A 356 HIS ARG THR VAL HIS ALA GLY GLU VAL GLY SER ALA ASN SEQRES 18 A 356 VAL VAL LYS GLU ALA VAL ASP THR LEU LYS THR GLU ARG SEQRES 19 A 356 LEU GLY HIS GLY TYR HIS THR LEU GLU ASP THR THR LEU SEQRES 20 A 356 TYR ASN ARG LEU ARG GLN GLU ASN MET HIS PHE GLU ILE SEQRES 21 A 356 CYS PRO TRP SER SER TYR LEU THR GLY ALA TRP LYS PRO SEQRES 22 A 356 ASP THR GLU HIS ALA VAL ILE ARG PHE LYS ASN ASP GLN SEQRES 23 A 356 VAL ASN TYR SER LEU ASN THR ASP ASP PRO LEU ILE PHE SEQRES 24 A 356 LYS SER THR LEU ASP THR ASP TYR GLN MET THR LYS LYS SEQRES 25 A 356 ASP MET GLY PHE THR GLU GLU GLU PHE LYS ARG LEU ASN SEQRES 26 A 356 ILE ASN ALA ALA LYS SER SER PHE LEU PRO GLU ASP GLU SEQRES 27 A 356 LYS LYS GLU LEU LEU ASP LEU LEU TYR LYS ALA TYR ARG SEQRES 28 A 356 MET PRO SER PRO ALA HET ZN 400 1 HET FR6 1001 24 HETNAM ZN ZINC ION HETNAM FR6 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}- HETNAM 2 FR6 1H-IMIDAZOLE-4-CARBOXAMIDE HETSYN FR6 FR233623 FORMUL 2 ZN ZN 2+ FORMUL 3 FR6 C19 H21 N3 O2 FORMUL 4 HOH *186(H2 O) HELIX 1 1 ASP A 19 ALA A 21 5 3 HELIX 2 2 LYS A 23 ARG A 34 1 12 HELIX 3 3 THR A 42 GLY A 51 1 10 HELIX 4 4 THR A 57 MET A 69 1 13 HELIX 5 5 PRO A 70 ILE A 72 5 3 HELIX 6 6 CYS A 75 LYS A 92 1 18 HELIX 7 7 PRO A 104 ALA A 108 5 5 HELIX 8 8 ILE A 115 GLN A 119 5 5 HELIX 9 9 THR A 125 GLY A 145 1 21 HELIX 10 10 GLN A 158 SER A 160 5 3 HELIX 11 11 TRP A 161 TYR A 172 1 12 HELIX 12 12 GLY A 190 LEU A 193 5 4 HELIX 13 13 PHE A 194 GLY A 208 1 15 HELIX 14 14 SER A 220 THR A 230 1 11 HELIX 15 15 TYR A 240 GLU A 244 5 5 HELIX 16 16 ASP A 245 GLU A 255 1 11 HELIX 17 17 CYS A 262 GLY A 270 1 9 HELIX 18 18 HIS A 278 ASP A 286 1 9 HELIX 19 19 ASP A 296 LYS A 301 1 6 HELIX 20 20 THR A 303 MET A 315 1 13 HELIX 21 21 THR A 318 SER A 332 1 15 HELIX 22 22 PRO A 336 TYR A 351 1 16 SHEET 1 A 8 LYS A 11 HIS A 17 0 SHEET 2 A 8 VAL A 95 TYR A 102 1 O ARG A 101 N VAL A 16 SHEET 3 A 8 LYS A 147 MET A 155 1 O CYS A 153 N TYR A 102 SHEET 4 A 8 VAL A 177 ALA A 183 1 O ALA A 183 N CYS A 154 SHEET 5 A 8 HIS A 210 ALA A 215 1 O HIS A 210 N ILE A 180 SHEET 6 A 8 ARG A 235 HIS A 238 1 O GLY A 237 N VAL A 213 SHEET 7 A 8 HIS A 258 ILE A 261 1 O GLU A 260 N LEU A 236 SHEET 8 A 8 ASN A 289 LEU A 292 1 O ASN A 289 N PHE A 259 CISPEP 1 GLU A 113 PRO A 114 0 -9.45 CISPEP 2 GLN A 175 THR A 176 0 -18.72 CRYST1 78.410 78.410 137.460 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012753 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012753 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007275 0.00000